Delivery Order SPE2DB22D1106-SPE2DB25FEKP3
Award Date
4/25/25
Potential Completion Date
4/28/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,373.20 firm fixed-price contract is for the delivery of 10,000 unit vials of the medication Pregnyl, with a completion date of December 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,115.75, is for the delivery of 10,000 unit vials of the medication Pregnyl. The contract is a firm fixed-price, non-set-aside award with a completion date of May 8, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 10,000 unit vials of the pharmaceutical product Pregnyl. The contract has a Firm Fixed Price (FFP) type and a ceiling value of $1,180.24. The contract is not set aside. Amerisourcebergen, a major pharmaceutical distributor, will deliver the Pregnyl vials to the DLA, which supports medical needs across the U.S. Department of Defense and other federal agencies. This delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,388.96 firm fixed-price contract is for the delivery of 4,565,131,503 vials of Pregnyl 10,000 unit medication. The contract has a completion date of July 15, 2024 and was awarded on July 12, 2024. There is no set-aside designation for this contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pregnyl 10,000 unit vials, a pharmaceutical product, with a ceiling value of $1,029.90. The contract is a firm fixed-price, delivery order contract with a completion date of November 29, 2024. AmerisourceBergen is a for-profit organization and is registered in the System for...
This federal contract award, valued at $3,240.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10,000 unit vials of the medication Pregnyl, a hormone treatment. This is a firm fixed-price delivery order contract with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, with an identifier of SPE2DB22D1106|SPE2DB25FEGU0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567843197 units of Pregnyl 10,000 unit vials, with an ultimate completion date of April 9, 2025 and a ceiling value of $1,813.50. The contract is a Delivery Order with a Firm Fixed Price pricing type, and is not designated with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $73,241.31, is for the delivery of pharmaceutical and medical products to the DLA's Pharmaceutical Prime Vendor Division for the Federal Supply Bureau. The contract is a firm fixed-price delivery order with a performance period that extends through May 9, 2025. AmerisourceBergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,627.68, is for the provision of pharmaceutical and medical products to support the DLA's Pharmaceutical Prime Vendor (PV) Division. It is a firm-fixed-price delivery order contract with a performance period through May 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,028.48, is for the delivery of pharmaceutical and medical products to the DLA's Pharmaceutical Prime Vendor Division. It is a firm-fixed-price contract with an ultimate completion date of April 24, 2025. The contract is not set aside and is open to competition. AmerisourceBergen...